4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001593968-24-000197
Chief Technical Officer acquired 96,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MOORE TIMOTHY L. · Chief Technical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-25 | Grant or award : show line 1 in the form | +96,600 | 282,819 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-25 | Grant or award : show line 2 in the form Stock Option (Right to buy) | +341,515 | 341,515 | D |
Loading xslF345X05/primary_01.xml…